What are the 4 P's of ulcerative colitis?

Ulcerative colitis is a chronic gastrointestinal condition defined by ongoing colon inflammation that can flare and settle over time. This article explains the “4 P’s” of ulcerative colitis—Precision, Pathology, Predisposition, and Persistence—and shows how they shape diagnosis, everyday management, and long-term digestive health. You will learn why symptoms alone do not always reveal what drives disease activity, how the gut microbiome contributes to inflammation, and where personalized insights can help. For anyone navigating inflammatory bowel disease, understanding these pillars can clarify what’s happening inside the gut and highlight thoughtful, non-promotional ways to explore your individual biology.

Understanding Ulcerative Colitis and Its Impact on Gut Health

Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) that causes continuous inflammation of the colon’s inner lining, typically starting in the rectum and extending proximally. The hallmark symptoms—rectal bleeding, diarrhea, abdominal pain, urgency, and fatigue—reflect mucosal injury and immune activation in the large intestine. Yet UC is more than a cluster of digestive symptoms. Because the colon plays a central role in water absorption, electrolyte balance, immune tolerance, and hosting diverse microbes, ongoing colon inflammation can ripple outward into overall well-being, appetite, energy, and quality of life.

Many people living with UC find that day-to-day experiences vary widely, even when using similar therapies. Flares can emerge without a clear trigger. Some individuals have mild disease limited to the rectum; others experience more extensive colitis. Different bodies, immune responses, and gut microorganisms create different patterns. Recognizing those differences is essential for making sense of a chronic gastrointestinal condition that is common, complex, and heterogeneous.

Why This Topic Matters for Digestive Health

The global prevalence of IBD has steadily increased over recent decades, and millions of people worldwide live with UC. Beyond the obvious digestive discomforts, UC can influence work, social plans, nutrition, sleep, and mental health. Importantly, it is not just a matter of symptom relief; it is about understanding the biology driving inflammation so that care can be more informed and responsive. A stronger grasp of disease mechanisms can help people participate in shared decision-making and make practical adjustments—dietary strategies, stress management, and monitoring plans—that may complement medical care.

Addressing Symptoms vs. Root Causes

Symptoms like bleeding, urgency, and diarrhea are often the first signals that something is wrong. Still, symptoms alone do not always reveal the root cause of colon inflammation. For example, an infection, medication effect, or ischemic injury can sometimes mimic IBD flares. Even within UC, the same symptom set can arise from different underlying drivers—for instance, a shift in the gut microbiome, a barrier-function change in the colonic lining, or a new environmental trigger. Because of this uncertainty, relying exclusively on symptoms can lead to guessing, which may delay targeted management or overlook contributing factors. The 4 P’s framework offers a structured way to think about UC that prioritizes both the biology and the unique individual behind the symptoms.

Core Concept: The 4 P’s of Ulcerative Colitis

The 4 P’s—Precision, Pathology, Predisposition, and Persistence—encourage a comprehensive, person-centered understanding of ulcerative colitis. They are not a checklist or a diagnostic test. Instead, they help organize the moving parts of UC in a way that supports better questions and more individualized decisions:

• Precision: Why a personalized perspective matters, given variable symptoms and treatment responses.
• Pathology: What the inflammatory process actually looks like in the colon and how it differs from other conditions.
• Predisposition: How genetics, environment, lifestyle, and the microbiome influence susceptibility and flares.
• Persistence: Why UC tends to wax and wane, and what chronicity means for long-term digestive health.

P1: Precision – The Need for Personalized Understanding

No two people experience ulcerative colitis the same way. One person may have infrequent, mild flares; another may struggle with frequent urgency and anemia. Treatment response can vary widely as well, whether the plan involves anti-inflammatory medications, biologics, small molecules, or supportive nutrition strategies. These differences arise from unique immune profiles, colon regions involved, comorbidities, stress levels, microbiome composition, and diet. Therefore, a generic management path may miss key contributors or underemphasize factors that matter to an individual.

Precision in UC doesn’t mean replacing clinical judgment with technology; rather, it means combining individualized history, exam findings, and appropriate testing to tailor decisions. Biomarkers such as fecal calprotectin and C-reactive protein can support monitoring, while endoscopy and imaging assess mucosal healing and complications. Stool and microbiome analyses may provide additional context about microbial diversity and dysbiosis, which can influence symptoms and inflammation. This layered approach acknowledges that the same symptom profile can stem from different biological processes—and is more likely to identify practical next steps than guesswork alone.

Personalized understanding also includes daily life factors that are easy to overlook: patterns of food tolerance, sleep regularity, recent antibiotic exposure, and changes in stress or physical activity. Documenting these elements and comparing them with objective markers can help clarify what is coincidence versus correlation, potentially pointing to better-timed adjustments and more efficient follow-up plans.

P2: Pathology – The Underlying Inflammatory Process

Ulcerative colitis is characterized by continuous inflammation of the colonic mucosa, usually starting in the rectum and extending proximally in a contiguous fashion. The pathology predominantly involves the inner mucosal layer, leading to superficial ulcerations, friability, and bleeding. Immune activation in UC involves innate and adaptive arms: epithelial barrier disruption allows microbial products to interact with immune cells, while T-cell responses, cytokines, and chemokines sustain an inflammatory loop. Although UC is often described as having a “Th2-like” immune signature compared with Crohn’s disease, the reality is more complex, with contributions from Th17 pathways, innate lymphoid cells, and neutrophil activity.

Understanding this inflammatory cascade explains many clinical features. For example, rectal involvement can cause urgency and tenesmus. Mucus production changes reflect goblet cell dysfunction. Blood and stool frequency mirror active mucosal injury. Systemic effects such as fatigue can be linked to inflammatory cytokines and iron deficiency from blood loss. Importantly, colon inflammation in UC is mucosal and continuous, which helps differentiate it from Crohn’s disease, where inflammation may be patchy, transmural, and can involve any part of the gastrointestinal tract.

UC also needs to be distinguished from other types of colitis. Infectious colitis can mimic UC symptoms but usually has different triggers and a self-limiting course in many cases. Ischemic colitis arises from reduced blood flow and tends to have a distinct distribution and acute presentation. Microscopic colitis presents with chronic watery diarrhea but shows characteristic histological changes under the microscope without visible ulcers on colonoscopy. Clarifying the pathology is essential because mislabeling the process can lead to mismatched expectations and strategies.

P3: Predisposition – Genetic and Environmental Factors

Why do some people develop UC while others do not, even in similar environments? Predisposition encompasses genetic susceptibilities, environmental exposures, and lifestyle factors that shape immune tolerance and gut ecology. While no single gene “causes” UC, genome-wide studies have identified multiple risk loci, including regions linked to immune regulation and epithelial barrier function (for example, HLA regions, IL23R-related pathways, and ECM1). Family history modestly increases risk, but most people with UC do not have a first-degree relative with IBD—highlighting that genes are influential yet not determinative.

Environmental and lifestyle factors likely modulate risk by altering the gut microbiome, mucosal immunity, and barrier integrity. Diets high in ultra-processed foods, emulsifiers, and certain fats have been associated with dysbiosis and increased intestinal permeability in experimental and observational studies. Prior antibiotic exposures can shift microbial communities in ways that reduce resilience. Nonsteroidal anti-inflammatory drugs (NSAIDs) may irritate the gut lining in some individuals. Sleep disruption, chronic stress, and smoking status can also play roles, although the relationships are nuanced. Notably, active cigarette smoking is associated with a lower incidence of UC but carries major health risks overall and is not recommended as a strategy for disease prevention or control. These complex, interwoven factors help explain why disease onset and flare patterns differ so much from person to person.

Diet remains a frequent question. While no single diet cures UC, many people identify patterns related to fiber type, fat quality, fermentable carbohydrates, and additive exposure that influence symptoms. The gut microbiome mediates many of these effects by producing metabolites (like short-chain fatty acids) that support epithelial barrier health or, conversely, by generating pro-inflammatory signals when balance is disrupted. Personalized exploration—especially when paired with objective markers—can help separate supportive patterns from coincidental ones.

P4: Persistence – The Chronic Nature and Recurrence

Ulcerative colitis is a chronic condition characterized by periods of remission and flare. Even when symptoms settle, low-level inflammation can smolder, and external triggers may reignite activity. Persistence does not mean constant severity; rather, it reflects the underlying biology of immune dysregulation, barrier vulnerability, and microbial instability that can recur over time. Adherence to medical therapy, monitoring plans, and attention to individualized triggers often plays a central role in sustaining remission and minimizing complications.

The gut microbiome is integral to this persistence. Recurrent dysbiosis—marked by reduced diversity, decreased beneficial butyrate producers, and increased pro-inflammatory taxa—can perpetuate immune activation. On the other hand, a stable, diverse microbial community can help reinforce mucosal defenses. Factors like stress, infections, medication changes, and dietary shifts can tip the balance. Recognizing this cycle helps make sense of why symptoms sometimes resurface after seemingly minor disruptions and underscores the value of pairing symptom tracking with deeper biological context.

The Role of the Gut Microbiome in Ulcerative Colitis

Microbiome Imbalances and Inflammation

The human colon contains a dense, dynamic ecosystem of microbes that interact continuously with the immune system and the epithelial barrier. In UC, research frequently observes dysbiosis—an imbalance in composition and function—characterized by lower overall diversity and changes in key groups of bacteria. For instance, beneficial butyrate-producing organisms from the Firmicutes phylum (such as certain Clostridial clusters) may be reduced, while Proteobacteria and other opportunistic taxa can be enriched during active inflammation. Butyrate, a short-chain fatty acid produced by fiber-fermenting microbes, is a crucial fuel for colonocytes and supports anti-inflammatory signaling and tight junction integrity. When butyrate producers are scarce, the barrier may be more vulnerable, and immune responses can tilt toward inflammation.

Dysbiosis is not just about which species are present; it is about what they are doing. Microbes generate metabolites that influence immune tolerance, mucus thickness, and epithelial repair. Changes in bile acid profiles, tryptophan metabolites, and bacterial lipopolysaccharides (LPS) can all shape immune tone. If the mucus layer thins or epithelial junctions loosen, microbial components gain broader access to immune cells, potentially fueling a self-perpetuating loop of inflammation. Conversely, when microbial communities are diverse and balanced, they often produce signals that encourage regulatory immune pathways, helping the colon maintain equilibrium.

Microbiome Variability and Its Impact

There is no single “UC microbiome.” Geography, diet, medications, age, early-life exposures, and genetics all influence which species take root, how they interact, and what metabolites they produce. Two people with similar symptoms can have very different microbial profiles; likewise, one individual’s microbiome can shift markedly across time. Because of this variability, symptoms alone cannot fully explain microbiome health, and one-size-fits-all recommendations often fall short. Understanding each person’s microbial landscape can help frame realistic expectations and promote targeted experimentation with diet, fiber types, or probiotics—especially when guided by clinical support and objective measures.

How Microbiome Testing Provides Insight into UC

What a Microbiome Test Can Reveal

Microbiome testing analyzes the genetic material of microbes in a stool sample to estimate which organisms are present and in what relative proportions. Depending on the method (for example, 16S rRNA gene sequencing versus shotgun metagenomics), a test can report overall diversity, the relative abundance of key bacterial groups, and the presence of certain taxa linked to health or dysbiosis. Some tests also infer potential functional capacities—such as pathways related to short-chain fatty acid production or bile acid metabolism—based on known microbial gene sets. While a microbiome test is not a diagnostic tool for ulcerative colitis and cannot replace clinical evaluation, it can provide additional context about microbial balance and potential drivers of symptoms.

2-minute self-check Is a gut microbiome test useful for you? Answer a few quick questions and find out if a microbiome test is actually useful for you. ✔ Takes 2 minutes ✔ Based on your symptoms & lifestyle ✔ Clear yes/no recommendation Check if a test is right for me →

In the UC setting, a stool microbiome profile may highlight:

• Diversity and balance: Whether your microbial community is broadly diverse or dominated by a few groups.
• Beneficial taxa: Relative levels of fiber-fermenting, butyrate-producing organisms that support barrier integrity.
• Opportunistic or pro-inflammatory taxa: Organisms that tend to expand during dysbiosis, which may correlate with symptoms or active inflammation.
• Functional signals (inferred): Potential capacity for producing metabolites relevant to colon health, such as short-chain fatty acids.

These insights are educational. They can help frame discussions with your healthcare team, add depth to diet and lifestyle adjustments, and provide a baseline to compare against during future flares or remissions. If you’re considering a neutral way to learn about your gut ecosystem, a thoughtfully designed microbiome test can be a useful information source without replacing clinical care.

Relevance for Colitis Management and Chronic GI Conditions

For people living with chronic gastrointestinal conditions, understanding microbial balance can complement symptom tracking. If a test suggests low diversity with reduced butyrate producers, a care team might consider how fiber types, fermentable substrates, or probiotic strategies fit within the broader plan. If an opportunistic species is dominant, it may prompt a closer look at recent antibiotics, infections, or dietary patterns. Importantly, microbiome data should be interpreted in context—alongside clinical history, lab markers like fecal calprotectin, and endoscopic findings where relevant. The value lies in integrating signals rather than over-relying on any single result.

Microbiome analysis can also support longitudinal learning. Repeating a stool microbiome analysis after a significant dietary shift, stressor, or medication change may reveal patterns that symptoms alone did not capture. Over time, this can reduce guessing, highlight hidden imbalances, and make tailored strategies more evidence-informed. For those exploring gut health systematically, a stool microbiome analysis can serve as one layer of insight among several.

Who Should Consider Microbiome Testing?

• People with an existing diagnosis of ulcerative colitis or other inflammatory bowel diseases who want to understand microbial balance as part of their digestive health plan.
• Individuals with recurrent or unresponsive colon inflammation where symptoms don’t clearly align with known triggers.
• Those experiencing variability in symptoms—good weeks and bad weeks—without clear explanations from routine labs alone.
• Anyone curious about proactive digestive health who wants to learn how diet, stress, sleep, and medications may influence their gut ecosystem.
• People who have tried generalized dietary advice but prefer a more individualized, data-informed approach to colitis management.

Decision-Support: When Does Microbiome Testing Make Sense?

Microbiome testing can be most useful when it answers a focused question or supports a specific decision. Consider whether any of the following fit your situation:

• Diagnostic uncertainty or atypical symptoms: If your clinical picture is unclear or overlapping conditions are suspected, a microbiome snapshot may help frame next steps—recognizing it does not diagnose UC.
• Flares despite standard treatment: If symptoms recur and routine tests don’t fully explain why, microbial data may identify hidden imbalances or suggest directions for dietary fine-tuning.
• Monitoring response to microbiome-targeted changes: If you have adjusted fiber types, introduced probiotics, or modified diet substantially, a repeat test can help you see whether microbial balance shifted.
• Long-term management and personalization: For ongoing optimization—especially if you track symptoms, biomarkers, and lifestyle factors—microbiome data adds a layer that can make patterns more visible.

In each scenario, interpretation is key. Using results to inform conversations with your clinician, dietitian, or care team helps ensure that microbiome insights are integrated safely and sensibly. For readers looking to add this perspective, a balanced, non-promotional option like a personalized gut health report can provide structured, comprehensible results to discuss with your healthcare provider.

Why Symptoms Don’t Always Reveal the Root Cause

Symptoms reflect the body’s response to ongoing processes, but they do not specify what is driving those processes. Diarrhea and bleeding may stem from active UC, but similar symptoms can appear with infections or medication-related irritation. Urgency can occur from rectal inflammation, but also from altered motility in times of high stress. Even when UC is the cause, two people with identical stool patterns can have very different underlying microbiome profiles or immune signals. This is why symptom-led guessing can be frustrating: it conflates output (what you feel) with mechanism (why it’s happening). Layering symptoms with objective data—labs, imaging, endoscopy, and optionally microbiome profiles—reduces uncertainty and guides more focused problem-solving.

Practical Considerations and Limitations of Microbiome Testing

Stool microbiome tests come in different formats. 16S rRNA gene sequencing groups bacteria by broader categories and is cost-effective, while shotgun metagenomics can resolve organisms at the species level and infer more functions, typically at a higher cost. Both approaches provide relative—not absolute—abundances, and results can be influenced by diet, transit time, medications, and recent illnesses. A single test is a snapshot; longitudinal testing is better for understanding trends.

Important limitations include:

• Microbiome tests do not diagnose ulcerative colitis or determine medication needs.
• Results require context; correlation does not equal causation.
• Interventions based solely on microbiome data may miss other clinical priorities.
• Quality and interpretation vary by provider; seek transparent methods and clear, educational reporting.

When used thoughtfully, microbiome insights complement—not replace—medical care. Discuss plans with your healthcare team, especially if you are considering significant dietary changes or supplements.

Integrating the 4 P’s With Everyday Colitis Management

Precision encourages a personalized plan: track your own triggers, note patterns, and use appropriate tests to confirm conjectures. Pathology reminds us that mucosal healing matters, and that endoscopic and histologic markers provide information symptoms may not. Predisposition keeps attention on factors you can influence—dietary quality, stress, sleep, medication exposures—even if you cannot change your genes. Persistence prepares you for a condition that can recur, motivating maintenance strategies and regular check-ins.

Combining these elements with microbiome awareness can be powerful. If your data suggest reduced diversity and low butyrate producers, you might discuss with your clinician how to safely explore fiber types you tolerate, consider probiotic options, or time dietary changes with objective monitoring. If your microbiome looks relatively stable but symptoms persist, you might look more closely at other factors—such as iron deficiency, bile acid malabsorption, or functional bowel overlays—that sometimes coexist with IBD. The key is to replace broad assumptions with targeted hypotheses and measurable follow-up.

Examples of How the 4 P’s Guide Real-World Decisions

Scenario 1: Similar Symptoms, Different Microbiome Profiles

Two individuals with UC report three loose stools daily and mild bleeding. One has very low microbial diversity and reduced levels of butyrate-producing bacteria; the other shows near-average diversity. While both require clinical assessment, the first may benefit from a careful review of fiber tolerance and fermentable substrates, whereas the second might warrant attention to non-microbial factors (e.g., medication timing, iron deficiency, or rectal disease activity). In both cases, objective markers like fecal calprotectin help validate whether symptoms align with active inflammation.

Scenario 2: Flare After Antibiotics

A person in remission develops urgency and bleeding after a course of antibiotics for a respiratory infection. Microbiome testing performed for educational context shows reduced diversity and a spike in opportunistic taxa. With clinical confirmation of increased inflammation, the care team may consider standard medical options while discussing supportive steps for microbial recovery. A follow-up test in several weeks can help document whether the microbiome is stabilizing as symptoms improve.

Scenario 3: Persistent Symptoms With Low Inflammatory Markers

Another individual reports bloating and looser stools, but fecal calprotectin and CRP are low, and endoscopy shows mild or no active inflammation. Here, the differential expands beyond UC activity to include food intolerances, small intestinal bacterial overgrowth, bile acid diarrhea, pelvic floor dysfunction, or irritable bowel syndrome overlap. Microbiome results might reveal patterns consistent with fermentation issues or functional dysbiosis. The findings can inform a stepwise approach to diet and further evaluation without assuming all symptoms stem from UC inflammation.

How to Discuss Microbiome Results With Your Care Team

Bringing results to a visit is most useful when you frame specific questions:

• Do these findings help explain my current symptoms or lab results?
• Which patterns should we monitor over time (e.g., diversity, specific taxa)?
• Are there safe, evidence-informed diet or probiotic adjustments worth trying for a set period?
• What additional tests, if any, could clarify uncertainties (e.g., fecal calprotectin, iron studies)?
• When should I recheck my microbiome, if at all?

These conversations keep microbiome data anchored in clinical reality and support gradual, measurable changes rather than sweeping, untested overhauls.

Concluding: Connecting the 4 P’s, Microbiome, and Personal Gut Health

The 4 P’s—Precision, Pathology, Predisposition, and Persistence—offer a clear framework for understanding ulcerative colitis beyond symptoms. UC involves a complex interplay of immune pathways, epithelial barrier function, genetics, environment, and the gut microbiome. While no single test or strategy answers every question, thoughtfully integrating symptom tracking with objective markers and, when appropriate, evidence-informed microbiome testing can reduce guesswork and surface insights hidden from day-to-day observation. Ultimately, an individualized approach—grounded in science, guided by careful monitoring, and respectful of each person’s lived experience—supports more confident, collaborative colitis management.

Key Takeaways

• The 4 P’s—Precision, Pathology, Predisposition, Persistence—organize how ulcerative colitis develops, fluctuates, and affects daily life.
• Symptoms signal a problem but do not always identify the underlying driver of colon inflammation.
• UC pathology involves continuous mucosal inflammation, typically starting in the rectum and extending proximally.
• Genetics, environment, lifestyle, and the gut microbiome all shape susceptibility and flare patterns.
• Dysbiosis—low diversity and shifts in key taxa—can contribute to ongoing inflammation in the colon.
• Microbiome testing is not diagnostic but can reveal microbial balance and potential functional capacities.
• Integrating microbiome data with clinical markers reduces guesswork and supports targeted experimentation.
• Longitudinal tracking of symptoms, labs, and microbiome patterns can make trends more visible over time.
• Personalized strategies, developed with your healthcare team, are more effective than one-size-fits-all advice.
• Evidence-aware, non-promotional tools—such as a structured microbiome analysis—can inform education and planning.

Frequently Asked Questions

What are the 4 P’s of ulcerative colitis?

The 4 P’s are Precision, Pathology, Predisposition, and Persistence. They provide a structured way to understand how UC starts, how it behaves over time, why it varies among individuals, and how person-specific insights can inform management decisions.

Is ulcerative colitis the same as Crohn’s disease?

No. Both are types of inflammatory bowel disease, but they differ in location and depth of inflammation. UC typically involves continuous mucosal inflammation in the colon starting at the rectum, while Crohn’s disease can affect any part of the GI tract with patchy, transmural inflammation.

Why can symptoms be misleading in UC?

Similar symptoms can arise from different causes, including infections, medication effects, or functional bowel conditions. Even within UC, the same symptom pattern can result from distinct microbial or immune processes. Objective markers and, when appropriate, microbiome data help clarify what’s driving symptoms.

2-minute self-check Is a gut microbiome test useful for you? Answer a few quick questions and find out if a microbiome test is actually useful for you. ✔ Takes 2 minutes ✔ Based on your symptoms & lifestyle ✔ Clear yes/no recommendation Check if a test is right for me →

What role does the gut microbiome play in UC?

The colon’s microbial community influences immune tone, mucus integrity, and barrier function. In UC, dysbiosis—reduced diversity and shifts in key taxa—can promote inflammation. Balanced, diverse communities tend to support regulatory pathways that help maintain colonic health.

Can diet cure ulcerative colitis?

No single diet cures UC. However, dietary patterns can influence symptoms and microbial balance. Many people, with clinical guidance, explore fiber types, fermentable carbohydrates, and overall diet quality to find practical strategies that complement medical care.

What can a microbiome test tell me about my UC?

It can provide an overview of microbial diversity, relative abundance of beneficial and opportunistic taxa, and inferred functional capacities (e.g., short-chain fatty acid potential). While not diagnostic, this information can help frame discussions around diet and monitoring with your healthcare team.

Is microbiome testing a replacement for colonoscopy or lab tests?

No. Microbiome testing is an educational tool that complements, not replaces, clinical evaluation. Endoscopy, imaging, and inflammatory biomarkers remain central to diagnosis and assessing disease activity in ulcerative colitis.

Who might benefit most from microbiome testing?

People with UC who want to understand microbial balance, those with recurrent or unexplained flares, and individuals pursuing personalized digestive health strategies may find value. It is also helpful for those tracking changes after diet or probiotic adjustments.

How often should I test my microbiome?

There is no universal schedule. Some test once to establish a baseline; others repeat after meaningful changes—like a new diet, medication, or flare—to compare trends. Discuss timing with your care team to align testing with clinical goals.

What are common limitations of microbiome tests?

They provide relative abundances, are influenced by short-term factors, and cannot diagnose UC or determine medications. Results require clinical context, and not all reported associations imply causation.

Do probiotics help with ulcerative colitis?

Some probiotics have been studied for IBD, and certain strains may support specific goals, such as maintaining remission in select contexts. Responses vary, and it is best to discuss options with your clinician to ensure safety, realistic expectations, and alignment with your overall plan.

How can I use microbiome results responsibly?

Use them to ask targeted questions, guide cautious dietary experiments, and plan follow-up measurements. Integrate findings with symptoms, labs, and medical advice, and avoid making major changes based on a single data point.

Keywords

ulcerative colitis, inflammatory bowel disease, colon inflammation, chronic gastrointestinal condition, digestive health, colitis management, gut microbiome, dysbiosis, microbial diversity, personalized gut health, mucosal healing, short-chain fatty acids, butyrate, immune modulation, epithelial barrier, precision medicine, remission and flare, stool microbiome analysis, microbiome testing